NSE · FREDUN

Fredun Pharmaceuticals Limited

Sector: Healthcare · ISIN: INE194R01017

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#1,685

of 5,084 stocks

🏆 New peak

▲ 421W

Peak #1,685 · 30 Sep 2026

Fredun Pharmaceuticals Limited is a smallcap company in the Healthcare space and is growing revenue rapidly, trades at a moderate earnings multiple, and posts a modest return on equity. Ownership as of Jul 2026.

Market Cap

767.59 Cr

P/E Ratio

20.84

P/B Ratio

2.74

ROE

11.73%

ROCE

25.00%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	227.76 Cr	210.41 Cr	159.93 Cr	143.59 Cr
Net Profit	13.13 Cr	10.78 Cr	10.48 Cr	9.43 Cr
EPS	23.82	19.70	19.53	19.98
Operating Profit	29.17 Cr	25.73 Cr	24.55 Cr	20.44 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

44.57%

Public

55.43%

As of 16 Jul 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs